Novartis AG Common Stock (NVS)

Investing Cash Flow

-$3.09B

Quarterly · Period ending: · USD

NVS logo

NVS Investing Cash Flow

Latest reported-$3.09B
NVS Quarterly Cash from Investing ($1.53B → -$3.09B)
High-resolution chart · PNG

NVS investing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Novartis AG Common Stock Investing Cash Flow — Quarterly (USD)
Period endingInvesting Cash Flow (USD)
-3,090,390,700
-11,736,000,000
-2,111,178,114
-860,000,000
-2,243,000,000
330,000,000
-3,033,000,000
-374,000,000
-3,207,000,000
-899,000,000
-1,112,000,000
-2,860,000,000
-1,053,000,000
10,621,000,000
-1,467,000,000
5,198,000,000
-11,628,000,000
9,365,000,000
4,563,000,000
-1,232,000,000
97,000,000
780,000,000
-571,000,000
-2,045,000,000
-425,000,000
-10,141,000,000
318,000,000
-3,398,000,000
-474,000,000
1,328,000,000
-4,935,000,000
-886,000,000
4,325,000,000
-4,095,000,000
-996,000,000
-685,000,000
-337,000,000
-1,101,000,000
-1,073,000,000
-752,000,000
-844,000,000
-772,000,000
-1,690,000,000
-753,000,000
-1,784,000,000
-6,557,000,000
-919,000,000
54,000,000
-1,078,000,000
2,823,000,000
-2,655,000,000
-753,000,000
-640,000,000
696,000,000
-2,536,000,000
-1,971,000,000
-723,000,000
-445,000,000
-824,000,000
-569,000,000
110,000,000
491,000,000
-587,000,000
-10,662,000,000
-3,371,000,000
-1,136,000,000
-4,193,000,000
-4,452,000,000
-2,732,000,000
-2,842,000,000
-1,729,000,000
-13,123,000,000
1,051,000,000
3,434,000,000
-1,681,000,000
-2,588,000,000
-725,000,000
-1,250,000,000
-834,000,000
-480,000,000
-5,020,000,000
-241,000,000
-1,305,000,000
-3,332,000,000
-5,248,000,000
2,403,000,000
260,000,000
-1,570,000,000
-620,000,000
-1,289,000,000
-335,000,000
-925,000,000
14,000,000
-52,000,000
-1,114,000,000
1,534,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.